Planning 2025 clinical trials: Fast Approvals & 13% Early Bird Discount

News of September 24th, 2024

As we approach the end of Q3 and begin planning for 2025, we wanted to share some key advantages for your upcoming clinical trials:

Fast Approvals: Germany now guarantees approval times of just 26 days for mono-national clinical trials after successful validation. This streamlined process can significantly impact your 2025 timelines.
13% Early Bird Discount: At SocraTec R&D, we are offering an exclusive 13% Early Bird Discount for clinical trials in 2025, providing a valuable boost to your budget planning.

These two factors—time and budget—could make a substantial difference in your 2025 project planning.

Qualify for the discount by signing your contract for clinical trial execution in our Clinical Pharmacology Units (CPUs) in 2024.

Don’t miss this unique opportunity! Contact us to discuss your next project.

All fine on single